Skip to main content
Top
Published in: BMC Gastroenterology 1/2008

Open Access 01-12-2008 | Research article

The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria

Authors: AnJiang WANG, XianHua LIAO, LiShou XIONG, Sui PENG, YingLian XIAO, SiChun LIU, PinJin HU, MinHu CHEN

Published in: BMC Gastroenterology | Issue 1/2008

Login to get access

Abstract

Background

Epidemiological studies suggest considerable overlap between functional dyspepsia (FD) and irritable bowel syndrome (IBS). To date, no surveys have been performed to investigate the clinical overlap between these two disorders using Rome III criteria. Our aim was to investigate the prevalence and risk factors for the overlap of FD and IBS based on Rome III criteria in a large clinical sample.

Methods

Consecutive patients at the general gastroenterology outpatient clinic were requested to complete a self-report questionnaire. FD and IBS were defined by Rome III criteria.

Results

Questionnaires were returned by 3014 patients (52.8% female, 89% response rate). FD-IBS overlap was observed in 5.0% of the patients, while 15.2% and 10.9% of the patients were classified as FD alone and IBS alone, respectively. Compared with non-IBS patients, the odds ratio of having FD among IBS patients was 2.09 (95% CI: 1.68–2.59). Patients with FD-IBS overlap had higher severity scores for the postprandial fullness symptom (2.35 ± 1.49 vs. 1.72 ± 1.59, P < 0.001) and overall FD symptom (6.65 ± 2.88 vs. 5.82 ± 2.76, P = 0.002) than those with FD alone. The only independent risk factor for FD-IBS overlap vs. FD alone was the presence of postprandial fullness symptom (OR 2.67, 95% CI: 1.34–5.31).

Conclusion

Clinical overlap of FD and IBS according to Rome III criteria is very common. One risk factor for FD-IBS overlap is the presence of postprandial fullness symptom. This study provides clues for future pathophysiological studies of FD and IBS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Corsetti M, Caenepeel P, Fischler B, Janseens J, Tack J: Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol. 2004, 99: 1152-1159. 10.1111/j.1572-0241.2004.30040.x.CrossRefPubMed Corsetti M, Caenepeel P, Fischler B, Janseens J, Tack J: Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol. 2004, 99: 1152-1159. 10.1111/j.1572-0241.2004.30040.x.CrossRefPubMed
2.
go back to reference Chen MH, Zhong BH, Li CJ, Peng XZ, Hu PJ: An epidemiological study on dyspepsia in Guangdong area. Chin J Intern Med. 1998, 37: 312-314. Chen MH, Zhong BH, Li CJ, Peng XZ, Hu PJ: An epidemiological study on dyspepsia in Guangdong area. Chin J Intern Med. 1998, 37: 312-314.
3.
go back to reference Wang JL: Clinical epidemiology. 2001, Shanghai Science & Technology Press, 2 Wang JL: Clinical epidemiology. 2001, Shanghai Science & Technology Press, 2
4.
go back to reference Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, et al: The functional gastrointestinal disorders. 2006, Washington: Degnon, 3 Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, et al: The functional gastrointestinal disorders. 2006, Washington: Degnon, 3
5.
go back to reference Alizadeh-Naeeni M, Saberi-Firoozi M, Pourkhajeh A, Taheri H, Malekzadeh R, Derakhshan MH, Massarrat S, Iranian Functional Dyspepsia Study Group: Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study. Digestion. 2002, 66: 92-98. 10.1159/000065589.CrossRefPubMed Alizadeh-Naeeni M, Saberi-Firoozi M, Pourkhajeh A, Taheri H, Malekzadeh R, Derakhshan MH, Massarrat S, Iranian Functional Dyspepsia Study Group: Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study. Digestion. 2002, 66: 92-98. 10.1159/000065589.CrossRefPubMed
6.
go back to reference Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006, 101: 1581-1590. 10.1111/j.1572-0241.2006.00734.x.CrossRefPubMed Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006, 101: 1581-1590. 10.1111/j.1572-0241.2006.00734.x.CrossRefPubMed
7.
go back to reference Agreus L, Svardsudd K, Nyren O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995, 109: 671-680. 10.1016/0016-5085(95)90373-9.CrossRefPubMed Agreus L, Svardsudd K, Nyren O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995, 109: 671-680. 10.1016/0016-5085(95)90373-9.CrossRefPubMed
8.
go back to reference Stanghellini V, Tosetti C, Paternico A, De Giorgio R, Barbara G, Salvioli B, Corinaldesi R: Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol. 1999, 94: 2080-2085. 10.1111/j.1572-0241.1999.01281.x.CrossRefPubMed Stanghellini V, Tosetti C, Paternico A, De Giorgio R, Barbara G, Salvioli B, Corinaldesi R: Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol. 1999, 94: 2080-2085. 10.1111/j.1572-0241.1999.01281.x.CrossRefPubMed
9.
go back to reference Si JM, Wang LJ, Chen SJ, Sun LM, Dai N: Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol. 2004, 10: 1059-1064.PubMedPubMedCentral Si JM, Wang LJ, Chen SJ, Sun LM, Dai N: Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol. 2004, 10: 1059-1064.PubMedPubMedCentral
10.
go back to reference Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003, 98: 2454-2459. 10.1111/j.1572-0241.2003.07699.x.CrossRefPubMed Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003, 98: 2454-2459. 10.1111/j.1572-0241.2003.07699.x.CrossRefPubMed
11.
go back to reference Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992, 102: 1259-1268.CrossRefPubMed Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992, 102: 1259-1268.CrossRefPubMed
12.
go back to reference Crean GP, Holden RJ, Knill-Jones RP, Beattie AD, James WB, Marjoribanks FM, Spiegelhalter DJ: A database on dyspepsia. Gut. 1994, 35: 191-202. 10.1136/gut.35.2.191.CrossRefPubMedPubMedCentral Crean GP, Holden RJ, Knill-Jones RP, Beattie AD, James WB, Marjoribanks FM, Spiegelhalter DJ: A database on dyspepsia. Gut. 1994, 35: 191-202. 10.1136/gut.35.2.191.CrossRefPubMedPubMedCentral
13.
go back to reference Svedlund J, Sjodin I, Dotevall G, Gillberg R: Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Scand J Gastroenterol. 1985, 20: 595-601. 10.3109/00365528509089702.CrossRefPubMed Svedlund J, Sjodin I, Dotevall G, Gillberg R: Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Scand J Gastroenterol. 1985, 20: 595-601. 10.3109/00365528509089702.CrossRefPubMed
14.
go back to reference Perri F, Clemente R, Festa V, Annese V, Quitadamo M, Rutgeerts P, Andriulli A: Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying. Am J Gastroenterol. 1998, 93: 2082-2088. 10.1111/j.1572-0241.1998.00597.x.CrossRefPubMed Perri F, Clemente R, Festa V, Annese V, Quitadamo M, Rutgeerts P, Andriulli A: Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying. Am J Gastroenterol. 1998, 93: 2082-2088. 10.1111/j.1572-0241.1998.00597.x.CrossRefPubMed
15.
go back to reference Shah SS, Bhatia SJ, Mistry FP: Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001, 20: 103-106.PubMed Shah SS, Bhatia SJ, Mistry FP: Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001, 20: 103-106.PubMed
16.
go back to reference Chen MH, Zhong BB, Li CJ: A epidemiological study of dyspepsia in Guangdong area. J Gastroenterol Hepatol. 1997, 12: A199- Chen MH, Zhong BB, Li CJ: A epidemiological study of dyspepsia in Guangdong area. J Gastroenterol Hepatol. 1997, 12: A199-
17.
go back to reference Gwee KA, Teng L, Yeoh KG, Ho KY: Patients with functional dyspepsia who have symptoms of irritable bowel syndrome are more likely to have dysmotility-like than ulcer-like dyspepsia. Neurogastroenterol Motil. 2000, 12: 387- Gwee KA, Teng L, Yeoh KG, Ho KY: Patients with functional dyspepsia who have symptoms of irritable bowel syndrome are more likely to have dysmotility-like than ulcer-like dyspepsia. Neurogastroenterol Motil. 2000, 12: 387-
18.
go back to reference Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, Marengo M, Corinaldesi R: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996, 110: 1036-1042. 10.1053/gast.1996.v110.pm8612991.CrossRefPubMed Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, Marengo M, Corinaldesi R: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996, 110: 1036-1042. 10.1053/gast.1996.v110.pm8612991.CrossRefPubMed
19.
go back to reference Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J: Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia. Gastroenterology. 2001, 121: 526-535. 10.1053/gast.2001.27180.CrossRefPubMed Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J: Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia. Gastroenterology. 2001, 121: 526-535. 10.1053/gast.2001.27180.CrossRefPubMed
20.
go back to reference Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998, 115: 1346-1352. 10.1016/S0016-5085(98)70012-5.CrossRefPubMed Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998, 115: 1346-1352. 10.1016/S0016-5085(98)70012-5.CrossRefPubMed
21.
go back to reference Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J: Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003, 98: 783-788. 10.1111/j.1572-0241.2003.07389.x.CrossRefPubMed Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J: Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003, 98: 783-788. 10.1111/j.1572-0241.2003.07389.x.CrossRefPubMed
22.
go back to reference Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA: Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol. 1999, 94: 2929-2935. 10.1111/j.1572-0241.1999.01440.x.CrossRefPubMed Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA: Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol. 1999, 94: 2929-2935. 10.1111/j.1572-0241.1999.01440.x.CrossRefPubMed
23.
go back to reference van Wijk HJ, Smout AJ, Akkermans LM, Roelofs JM, ten Thije OJ: Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. Scand J Gastroenterol. 1992, 27: 99-102. 10.3109/00365529209096036.CrossRefPubMed van Wijk HJ, Smout AJ, Akkermans LM, Roelofs JM, ten Thije OJ: Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. Scand J Gastroenterol. 1992, 27: 99-102. 10.3109/00365529209096036.CrossRefPubMed
24.
go back to reference Evans PR, Bak YT, Shuter B, Hoschl R, Kellow JE: Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci. 1997, 42: 2087-2093. 10.1023/A:1018874602790.CrossRefPubMed Evans PR, Bak YT, Shuter B, Hoschl R, Kellow JE: Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci. 1997, 42: 2087-2093. 10.1023/A:1018874602790.CrossRefPubMed
25.
go back to reference Caballero-Plasencia AM, Valenzuela-Barranco M, Herrerias-Gutierrez JM, Esteban-Carretero JM: Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med. 1999, 26: 404-409. 10.1007/s002590050404.CrossRefPubMed Caballero-Plasencia AM, Valenzuela-Barranco M, Herrerias-Gutierrez JM, Esteban-Carretero JM: Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med. 1999, 26: 404-409. 10.1007/s002590050404.CrossRefPubMed
26.
go back to reference Acharya U, Waite N, Howlett P, Tanner AR, Smith CL: Failure to demonstrate altered gastric emptying in irritable bowel syndrome. Dig Dis Sci. 1983, 28: 889-892. 10.1007/BF01317038.CrossRefPubMed Acharya U, Waite N, Howlett P, Tanner AR, Smith CL: Failure to demonstrate altered gastric emptying in irritable bowel syndrome. Dig Dis Sci. 1983, 28: 889-892. 10.1007/BF01317038.CrossRefPubMed
27.
go back to reference Narducci F, Bassotti G, Granata MT, Pelli MA, Gaburri M, Palumbo R, Morelli A: Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci. 1986, 31: 241-246. 10.1007/BF01318114.CrossRefPubMed Narducci F, Bassotti G, Granata MT, Pelli MA, Gaburri M, Palumbo R, Morelli A: Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci. 1986, 31: 241-246. 10.1007/BF01318114.CrossRefPubMed
28.
go back to reference Nielsen OH, Gjorup T, Christensen FN: Gastric emptying rate and small bowel transit time in patients with irritable bowel syndrome determined with 99mTc-labeled pellets and scintigraphy. Dig Dis Sci. 1986, 31: 1287-1291. 10.1007/BF01299804.CrossRefPubMed Nielsen OH, Gjorup T, Christensen FN: Gastric emptying rate and small bowel transit time in patients with irritable bowel syndrome determined with 99mTc-labeled pellets and scintigraphy. Dig Dis Sci. 1986, 31: 1287-1291. 10.1007/BF01299804.CrossRefPubMed
29.
go back to reference Stanghellini V, Tosetti C, Barbara G, De Giorgio R, Cogliandro L, Cogliandro R, Corinaldesi R: Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol. 2002, 97: 2738-2743. 10.1111/j.1572-0241.2002.07062.x.CrossRefPubMed Stanghellini V, Tosetti C, Barbara G, De Giorgio R, Cogliandro L, Cogliandro R, Corinaldesi R: Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol. 2002, 97: 2738-2743. 10.1111/j.1572-0241.2002.07062.x.CrossRefPubMed
Metadata
Title
The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
Authors
AnJiang WANG
XianHua LIAO
LiShou XIONG
Sui PENG
YingLian XIAO
SiChun LIU
PinJin HU
MinHu CHEN
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2008
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-8-43

Other articles of this Issue 1/2008

BMC Gastroenterology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.